BMAL2 and breast carcinoma: BMAL2 has been implicated as an oncogenic driver in multiple human cancers, including lung, colorectal, and breast cancer,28 where it can drive tumorigenesis and create an immunosuppressive micro‐environment for advanced tumor growth.